ClinicalTrials.gov
public full text
Public Domain
Cilostazol Following Peripheral Endovascular Procedures
To compare the safety and effectiveness of dual anti-platelet therapy with cilostazol 100 mg twice daily and aspirin 100 mg daily versus monotherapy with aspirin 100 mg daily in patients undergoing peripheral angioplasty or stenting or both for the management of peripheral arterial disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?#1163084
- Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention#886774
- Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts#804374
- Ticagrelor Hemoadsorption Using Cytosorb® for Reduction of Bleeding During Cardiac Surgery#1044478
- Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery#904308
Record · ID 908750
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive